MiRNA-based therapy for cancer: MiRNA-135 suppresses the expression of oncomiR-17-92 in a cell-context dependent manner via down regulation of its target gene, 21/July/2014, 5.06 am

MiRNA-based therapy for cancer: MiRNA-135 suppresses the expression of oncomiR-17-92 in a cell-context dependent manner via down regulation of its target gene, 21/July/2014, 5.06 am

MiRNA-based therapy for cancer: MiRNA-135 suppresses the expression of oncomiR-17-92 in a cell-context dependent manner via down regulation of its target gene, 21/July/2014, 5.06 am 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, MiRNA-based therapy for cancer: MiRNA-135 suppresses the expression of OncomiR-17-92 in a cell context-dependent manner via down regulation of its target gene, 21/July/2014, 5.06 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation